BioCryst Pharmaceuticals.

BioCryst Pharmaceuticals landed $82 million in federal funding to explore its potential antiviral treatment for coronavirus called galidesivir. The drug has been in development since 2013 as a treatment...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT